Beijing Science Sun Pharmaceutical Co (SZSE:300485) Total Assets : ¥3,410.3 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Beijing Science Sun Pharmaceutical Co Total Assets?

Beijing Science Sun Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was ¥3,410.3 Mil.

During the past 12 months, Beijing Science Sun Pharmaceutical Co's average Total Assets Growth Rate was -9.90% per year. During the past 3 years, the average Total Assets Growth Rate was 10.60% per year. During the past 5 years, the average Total Assets Growth Rate was 13.30% per year. During the past 10 years, the average Total Assets Growth Rate was 25.80% per year.

During the past 13 years, Beijing Science Sun Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 76.00%. The lowest was 9.10%. And the median was 16.30%.

Total Assets is connected with ROA %. Beijing Science Sun Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 was -21.68%. Total Assets is also linked to Revenue through Asset Turnover. Beijing Science Sun Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.03.

Beijing Science Sun Pharmaceutical Co Total Assets Historical Data

The historical data trend for Beijing Science Sun Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Science Sun Pharmaceutical Co Total Assets Chart

Beijing Science Sun Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

2,805.50

2,991.06

3,401.65

3,569.08

3,622.20

Beijing Science Sun Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															3,548.63	3,777.45	3,704.23	3,622.20	3,410.25

Beijing Science Sun Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Beijing Science Sun Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	3467.591	+	154.61
	=	3,622.2

Beijing Science Sun Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	3275.307	+	134.942
	=	3,410.2

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Total Assets Explanation

Total Assets is connected with ROA %.

Beijing Science Sun Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-762.472	/	( (3622.202	+	3410.25)	/ 2 )
	=	-762.472	/	3516.226
	=	-21.68 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Beijing Science Sun Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	109.535	/	( (3622.202	+	3410.25)	/ 2 )
=	109.535	/	3516.226
=	0.03

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Beijing Science Sun Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Beijing Science Sun Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Science Sun Pharmaceutical Co Ltd (SZSE:300485) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

No. 8, Xingsheng Street, Yizhuang Economic and Technological Development Zone, Beijing, CHN, 100176

Website

http://www.ssyy.com.cn

Beijing Science Sun Pharmaceutical Co Ltd is engaged in the research and development, production and sales of biological drugs. The company products can be divided into cardiovascular series, immune regulation series, nervous system series, and other natural or biotech pharmaceuticals. Its products include Injection Tiopronin, Cybex, Xel, Lichinga, Plasmin Injection and Race liter.

Executives

Ma Li	Directors, executives
Kong Shuang Quan	Executives
Li Jian Hua	Director
Ma Biao	Directors, executives
Li Zhi Bing	Supervisors
Zhang Fan	Executives

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Headlines

No Headlines